| Acute effects of lysergic acid diethylamide in healthy subjects Y Schmid, F Enzler, P Gasser, E Grouzmann, KH Preller, FX Vollenweider, ... Biological psychiatry 78 (8), 544-553, 2015 | 314 | 2015 |
| LSD acutely impairs fear recognition and enhances emotional empathy and sociality PC Dolder, Y Schmid, F Müller, S Borgwardt, ME Liechti Neuropsychopharmacology 41 (11), 2638-2646, 2016 | 195 | 2016 |
| Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects F Mueller, C Lenz, PC Dolder, S Harder, Y Schmid, UE Lang, ME Liechti, ... Translational psychiatry 7 (4), e1084-e1084, 2017 | 86 | 2017 |
| Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects F Holze, P Vizeli, F Müller, L Ley, R Duerig, N Varghese, A Eckert, ... Neuropsychopharmacology 45 (3), 462-471, 2020 | 79 | 2020 |
| Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects PC Dolder, F Müller, Y Schmid, SJ Borgwardt, ME Liechti Psychopharmacology 235 (2), 467-479, 2018 | 75 | 2018 |
| Altered network hub connectivity after acute LSD administration F Müller, PC Dolder, A Schmidt, ME Liechti, S Borgwardt NeuroImage: Clinical 18, 694-701, 2018 | 74 | 2018 |
| Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations F Müller, C Lenz, P Dolder, U Lang, A Schmidt, M Liechti, S Borgwardt Acta Psychiatrica Scandinavica 136 (6), 648-657, 2017 | 72 | 2017 |
| Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects F Holze, P Vizeli, L Ley, F Müller, P Dolder, M Stocker, U Duthaler, ... Neuropsychopharmacology 46 (3), 537-544, 2021 | 64 | 2021 |
| Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin NL Mason, KPC Kuypers, F Müller, J Reckweg, DHY Tse, SW Toennes, ... Neuropsychopharmacology 45 (12), 2003-2011, 2020 | 64 | 2020 |
| Neuroimaging in moderate MDMA use: a systematic review F Mueller, C Lenz, M Steiner, PC Dolder, M Walter, UE Lang, ME Liechti, ... Neuroscience & Biobehavioral Reviews 62, 21-34, 2016 | 50 | 2016 |
| Acute LSD effects on response inhibition neural networks A Schmidt, F Müller, C Lenz, PC Dolder, Y Schmid, D Zanchi, UE Lang, ... Psychological medicine 48 (9), 1464-1473, 2018 | 39 | 2018 |
| Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects F Holze, U Duthaler, P Vizeli, F Müller, S Borgwardt, ME Liechti British journal of clinical pharmacology 85 (7), 1474-1483, 2019 | 36 | 2019 |
| Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis F Müller, R Brändle, ME Liechti, S Borgwardt Neuroscience & Biobehavioral Reviews 96, 10-20, 2019 | 35 | 2019 |
| Comparative effects of methylphenidate, modafinil, and MDMA on response inhibition neural networks in healthy subjects A Schmidt, F Müller, PC Dolder, Y Schmid, D Zanchi, ME Liechti, ... International Journal of Neuropsychopharmacology 20 (9), 712-720, 2017 | 23 | 2017 |
| Spontaneous and deliberate creative cognition during and after psilocybin exposure NL Mason, KPC Kuypers, JT Reckweg, F Müller, DHY Tse, B Da Rios, ... Translational psychiatry 11 (1), 1-13, 2021 | 22 | 2021 |
| Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain F Müller, ME Liechti, UE Lang, S Borgwardt Progress in brain research 242, 159-177, 2018 | 17 | 2018 |
| Acute effects of methylphenidate, modafinil, and MDMA on negative emotion processing A Schmidt, F Müller, PC Dolder, Y Schmid, D Zanchi, L Egloff, ME Liechti, ... International Journal of Neuropsychopharmacology 21 (4), 345-354, 2018 | 16 | 2018 |
| MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens F Müller, F Holze, P Dolder, L Ley, P Vizeli, A Soltermann, ME Liechti, ... Neuropsychopharmacology 46 (3), 545-553, 2021 | 13 | 2021 |
| A single dose of LSD does not alter gene expression of the serotonin 2A receptor gene (HTR2A) or early growth response genes (EGR1-3) in healthy subjects PC Dolder, E Grünblatt, F Müller, SJ Borgwardt, ME Liechti Frontiers in pharmacology 8, 423, 2017 | 11 | 2017 |
| Acute effects of lysergic acid diethylamide (LSD) on resting brain function F Müller, S Borgwardt Swiss Med Wkly, 2019 | 7 | 2019 |
